Human and Structural Factors Influencing the Control of Antimicrobacterial Resistance

Despite global efforts, antimicrobial resistance (AMR) has not been controlled.In 2024, the World Health Organization (WHO) updated its list of priority pathogens to include 15 families of resistant bacteria (critical, high, and medium).Today, the development, transmission, and spread of AMR remain uncharacterized, so the human and structural factors specific to each region that influence its control must be intensified and identified.Annually, 5 million people die from AMR, a number that will increase by 2030, with annual costs to health care and its management potentially reaching 412 billion USD.Unfortunately, it is common to prescribe antibiotics without microbiological studies, ignoring the adverse effects on the patient.A group of experts participated in the identification of 40 human health research priorities (WHO), which include global perspectives in low-and middle-income countries (LMICs).It is estimated that 40% of hospitalized patients receive antibiotics at some point, many of them unnecessarily, generating selective pressure for AMR.In Mexico, previous studies by our group reported an increase in multidrug resistance (MDR), extended-drug resistance (XDR), and pan-drug resistance (PDR), with 69% of gram-positive isolates having shown MDR, XDR or PDR.In fact, two cases of Pseudomonas aeruginosa from neonatal intensive care units showed PDR.An incomplete infrastructure, economy, and education system, as well as inappropriate training, cultural barriers, and uneven policies, contribute to AMR spread.The WHO points out that in developed countries, patients have a 50% adherence to treatment for chronic diseases, this being lower in developing countries.Thus, improving adherence to and proper use of antibiotics is a challenge for the global health system.Countries must implement national action plans (NAPs) and improve global coordination among governments, industries, and public and private organizations, providing resources for expert training and research

Authors

Institutions

Publication Details

Journal
Research in Medical & Engineering Sciences
Published
2024-12-17
DOI
https://doi.org/10.31031/rmes.2024.11.000762
Primary Topic
Antibiotic Use and Resistance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human and Structural Factors Influencing the Control of Antimicrobacterial Resistance

Jorge Manuel Sánchez González
Research in Medical & Engineering Sciences
Antibiotic Use and Resistance
article

Human and Structural Factors Influencing the Control of Antimicrobacterial Resistance

Jorge Manuel Sánchez González
article en

Abstract

Despite global efforts, antimicrobial resistance (AMR) has not been controlled.In 2024, the World Health Organization (WHO) updated its list of priority pathogens to include 15 families of resistant bacteria (critical, high, and medium).Today, the development, transmission, and spread of AMR remain uncharacterized, so the human and structural factors specific to each region that influence its control must be intensified and identified.Annually, 5 million people die from AMR, a number that will increase by 2030, with annual costs to health care and its management potentially reaching 412 billion USD.Unfortunately, it is common to prescribe antibiotics without microbiological studies, ignoring the adverse effects on the patient.A group of experts participated in the identification of 40 human health research priorities (WHO), which include global perspectives in low-and middle-income countries (LMICs).It is estimated that 40% of hospitalized patients receive antibiotics at some point, many of them unnecessarily, generating selective pressure for AMR.In Mexico, previous studies by our group reported an increase in multidrug resistance (MDR), extended-drug resistance (XDR), and pan-drug resistance (PDR), with 69% of gram-positive isolates having shown MDR, XDR or PDR.In fact, two cases of Pseudomonas aeruginosa from neonatal intensive care units showed PDR.An incomplete infrastructure, economy, and education system, as well as inappropriate training, cultural barriers, and uneven policies, contribute to AMR spread.The WHO points out that in developed countries, patients have a 50% adherence to treatment for chronic diseases, this being lower in developing countries.Thus, improving adherence to and proper use of antibiotics is a challenge for the global health system.Countries must implement national action plans (NAPs) and improve global coordination among governments, industries, and public and private organizations, providing resources for expert training and research

Research in Medical & Engineering SciencesVol. 11(3)
Mexfam (MX)
Zero hunger
Openalex Percentile: Top 68%
Antibiotic Use and Resistance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.